MBBS: Grant Medical College, Mumbai, India, 1996.

MD: Pediatrics, University of Mumbai, Mumbai, India, 1999.

Residency: Pediatrics, University of Mumbai, Mumbai, India, 1996-1999; Pediatrics, Children's Hospital of Michigan, Detroit, MI, 2001-2004.

Fellowship: Critical Care Medicine, Cincinnati Childrens Hospital Medical Center, 2004-2007.

Certification: Pediatrics, 2004.

Chima RS, Lamontagne T, Piraino G, Hake PW, Denenberg A, Zingarelli B. C-peptide, a novel inhibitor of lung inflammation following hemorrhagic shock. Am J Physiol Lung Cell Mol Physiol. 2011 May;300(5):L730-9.

Chima RS, Maltese G, Lamontagne T, Piraino G, Denenberg A, O'Connor M, Zingarelli B. C-Peptide ameliorates kidney injury following hemorrhagic shock. Shock. 2011 May;35(5):524-9.

Chima RS, Zingarelli B. Toll-like receptor-2 and disturbances of the cardiac rhythm: life changes in a heartbeat. Crit Care Med. 2010 Oct;38(10):2062-3.

Wong HR, Wheeler DS, Tegtmeyer K, Poynter SE, Kaplan JM, Chima RS, Stalets E, Basu RK, Doughty LA. Toward a clinically feasible gene expression-based subclassification strategy for septic shock: proof of concept. Crit Care Med. 2010 Oct;38(10):1955-61. 

Chima RS, Hake PW, Piraino G, Mangeshkar P, O'Connor M, Zingarelli B. Ciglitazone, a novel inhibitor of lung apoptosis following hemorrhagic shock. Int J Clin Exp Med. 2010 Jan 1;3(1):1-9. 

Chima RS, Hake P, Mangeshkar P, Piraino G, Denenberg A, Zingarelli B. Ciglitazone ameliorates lung inflammation by inhibiting NF-κB/IKK pathway in hemorrhagic shock. Crit Care Med. 2008 Oct;36(10):2849-57.

Chima RS, Zingarelli B. Surfactant treatment of neonatal acute respiratory distress syndrome: is "fortification" the answer? Crit Care Med. 2007;35(10):2442-3.